Search

Search Constraints

You searched for: Author/Creator Bond, David A.

Search Results

1. A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma. Issue 7 (7th June 2022)

2. Multi‐center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era. Issue 11 (10th August 2021)

3. Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure. Issue 2 (30th September 2019)

4. Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study. (July 2022)

5. Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib. Issue 1 (20th October 2022)

6. Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy. (5th December 2019)

7. Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose. Issue 7 (3rd July 2017)